Metagenomi Therapeutics, Inc. (Nasdaq: MGX) (the “Company”), an in vivo genome editing company capitalizing on its proprietary technologies to create curative genetic medicines for patients, today ...

A compact Cas12f nuclease shows high editing efficiency in human cells, with structural insights enabling an engineered variant potentially suited for future AAV‑compatible delivery.

Wealthier, more educated US communities recycle more plastic due to better access to industrial recycling facilities." ...

Researchers developed SynTrogo, a molecular tool enabling targeted synapse removal via engineered neuron–astrocyte ...

Perovskite solar cells shouldn’t work as well as they do—but they do. Scientists have now discovered that defects inside the ...

Nearly 80 percent of organizations now use AI in at least one core business process, according to McKinsey, yet widespread adoption has surfaced a persistent problem: a deep shortage of professionals ...

As transportation agencies and contractors across the country grapple with workforce development and long-term project ...

Scientists at the VIB–VUB Center for Structural Biology have uncovered a counterintuitive principle that could reshape how ...

Clues to the genetic code’s origin may be hidden in tiny protein fragments, revealing a synchronized and highly structured ...

Discover the latest press releases from Homoly Design + Build with the Kansas City Business Journal's BizSpotlight ...

Centromeres act as the control centers of chromosomes, ensuring accurate genetic inheritance during cell division, yet they ...